FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and is intended for treating hyperproliferation diseases and increasing bioavailability of preparation for hyperproliferation disease treating. Patients receiving simultaneously acidity reducing agents, such as proton pump inhibitors, and PI3K inhibitor, compound GDC-0941, on this therapy background preparations for repeated acidification are prescribed.
EFFECT: group of inventions allows improving of GDC-0941 bioavailability.
10 cl, 10 dwg, 1 tbl, 7 ex
| Title |
Year |
Author |
Number |
| NEW MEDICINAL FORMULATIONS OF SUBSTITUTED BENZIMIDAZOLES AND METHOD FOR THEIR USING |
2001 |
|
RU2279276C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF GASTRIC AND DUODENUM ULCER IN FORM OF SOLID GELATIN CAPSULES, WHICH CONTAINS RABEPRAZOLE OR ITS DERIVATIVES, AND METHOD OF ITS OBTAINING |
2007 |
- Shobolov Dmitrij L'Vovich
- Papazova Natal'Ja Aleksandrovna
|
RU2414889C2 |
| COMPOSITIONS AND METHODS FOR GASTRIC ACID SECRETION INHIBITION WITH USING SMALL DICARBOXYLIC ACID DERIVATIVES IN COMBINATION WITH PPI |
2007 |
- Marash Majkl
- Kostadinov Aleksej
- Atorot Tal
|
RU2467747C2 |
| COMPOSITION CONTAINING PROBIOTIC BACTERIA CAPABLE OF RESTORING THE BARRIER EFFECT OF THE STOMACH, LOST IN PROCESS OF PHARMACOLOGICAL TREATMENT OF INCREASED ACIDITY OF THE STOMACH |
2012 |
|
RU2685226C2 |
| PHARMACEUTICAL FORM FOR DRUG ADMINISTRATION IN COLON, METHOD OF DRUG ADMINISTRATION AND A METHOD OF PREPARING MATRICES FOR THIS FORM |
1991 |
- Amnon Sintov
- Abrakham Rubinshtejn
|
RU2113221C1 |
| USE OF ACYLFULVEN ANALOGS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1994 |
- Majkl Dzh.Kelner
- Trevor S.Makmorris
- Rajmond Titl
|
RU2145849C1 |
| COMBINATIONS OF ANTIBODY DRUG CONJUGATES AND CHEMOTHERAPEUTIC COMPOUNDS AND METHODS FOR USING |
2009 |
- Berri Linn
- Fillips Gejl L'Juis
- Slivkovski Mark Ks.
|
RU2510272C2 |
| COMBINATIONS OF ANTI-HER2-ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC REMEDIES, AND APPLICATION METHODS |
2018 |
- Berry, Leanne
- Phillips, Gail, Lewis
- Sliwkowski, Mark, X.
|
RU2781195C2 |
| COMBINATIONS OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS AND METHODS OF USE |
2013 |
- Berri Linn
- Fillips Gejl Lyuis
- Slivkovski Mark Ks.
|
RU2671489C2 |
| MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE-3-KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER |
2013 |
- Belvin Marsiya
- Fridman Lori
- Sampat Dipak
- Vallin Dzheffri
|
RU2665949C2 |
